Insider Transactions in Q4 2020 at Tracon Pharmaceuticals, Inc. (TCON)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2020
|
Ikarian Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
520,291
+16.07%
|
$4,682,619
$9.61 P/Share
|
|
Dec 29
2020
|
Charles Theuer PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.52%
|
$9,000
$9.98 P/Share
|
|
Dec 29
2020
|
Mark C Wiggins Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+3.4%
|
$10,000
$10.57 P/Share
|
|
Dec 22
2020
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
496,277
+17.79%
|
$3,970,216
$8.06 P/Share
|
|
Nov 11
2020
|
Ikarian Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.23%
|
$35,000
$7.53 P/Share
|
|
Oct 30
2020
|
Ikarian Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
21,300
+0.96%
|
$85,200
$4.64 P/Share
|
|
Oct 29
2020
|
Ikarian Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
7,700
+0.35%
|
$30,800
$4.77 P/Share
|
|
Oct 21
2020
|
Charles Theuer PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
2,000
+1.05%
|
$8,000
$4.38 P/Share
|
|
Oct 21
2020
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
8,656
+0.81%
|
$34,624
$4.4 P/Share
|